Benchmark Issues Positive Forecast for Nutex Health (NASDAQ:NUTX) Stock Price

Nutex Health (NASDAQ:NUTXFree Report) had its price objective raised by Benchmark from $45.00 to $60.00 in a research report sent to investors on Tuesday morning,Benzinga reports. They currently have a buy rating on the stock.

Separately, Maxim Group raised their target price on shares of Nutex Health from $45.00 to $50.00 and gave the stock a “buy” rating in a report on Tuesday.

Read Our Latest Analysis on Nutex Health

Nutex Health Trading Down 8.4 %

NASDAQ:NUTX opened at $28.70 on Tuesday. The stock has a fifty day simple moving average of $23.52 and a 200 day simple moving average of $14.22. The firm has a market capitalization of $156.04 million, a price-to-earnings ratio of -3.06 and a beta of 0.11. Nutex Health has a 1-year low of $4.16 and a 1-year high of $39.48. The company has a quick ratio of 1.55, a current ratio of 1.77 and a debt-to-equity ratio of 3.36.

Insider Activity

In related news, CFO Jon Christian Bates purchased 1,350 shares of Nutex Health stock in a transaction dated Thursday, August 22nd. The stock was acquired at an average cost of $21.46 per share, with a total value of $28,971.00. Following the completion of the transaction, the chief financial officer now directly owns 2,277 shares of the company’s stock, valued at $48,864.42. This trade represents a 145.63 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 38.52% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the stock. International Assets Investment Management LLC purchased a new position in Nutex Health in the third quarter valued at about $188,000. State Street Corp purchased a new stake in shares of Nutex Health during the 3rd quarter worth about $225,000. Thompson Davis & CO. Inc. acquired a new stake in shares of Nutex Health during the 3rd quarter valued at about $494,000. Finally, Essex Investment Management Co. LLC bought a new stake in shares of Nutex Health in the 3rd quarter valued at approximately $1,579,000. Institutional investors and hedge funds own 5.32% of the company’s stock.

About Nutex Health

(Get Free Report)

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.

Read More

Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.